Form4insider filings, from the source

Company · CIK 0001723128 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Amneal Pharmaceuticals, Inc. · AMRX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $7.2M · 3net −$7.2M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesSep 2025Nov 2025Jan 2026Mar 2026May 2026Jul 2026Sep 2026

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 17, 2026 GForm 4 →Sep 21, 4:33 pm EDTJ Kevin BuchiDirector20,445——75,077—
Sep 11, 2026 MForm 4 →Sep 14, 4:10 pm EDTJ Kevin BuchiDirector20,445$14.45$295,43095,522—
Sep 1, 2026 GForm 4 →Sep 2, 5:03 pm EDTAndrew S BoyerExecutive Vice President80,000——193,646—
Aug 21, 2026 GForm 4 →Aug 25, 4:41 pm EDTAndrew S BoyerExecutive Vice President152,426——273,646—
Aug 13, 2026 GForm 4 →Aug 14, 4:29 pm EDTJohn KielyDirector10,000——200,252—
Aug 13, 2026 SForm 4 →Aug 14, 4:29 pm EDTJohn KielyDirector50,000$17.64$882,000210,252−19.2%
Aug 12, 2026 SForm 4 →Aug 13, 4:22 pm EDTNikita ShahExecutive Vice President146,403$17.51$2,563,517253,390−36.6%
Aug 11, 2026 SForm 4 →Aug 13, 4:21 pm EDTJason B. DalyEVP, Chief Legal Officer216,613$17.41$3,771,05035,171−86.0%
Aug 11, 2026 MForm 4 →Aug 13, 4:21 pm EDTJ Kevin BuchiDirector168,573$17.18$2,896,08493,499—
Aug 10, 2026 AForm 4 →Aug 12, 6:06 pm EDTTushar Bhikhubhai Patel10% Owner12,763,469——61,341,678—
Aug 10, 2026 AForm 4 →Aug 12, 4:46 pm EDTChintu PatelCo-CEO, Director6,381,734——6,381,734—
Aug 10, 2026 AForm 4 →Aug 12, 4:39 pm EDTGautam PatelDirector283,632——283,632—
Aug 10, 2026 AForm 4 →Aug 12, 4:37 pm EDTChirag K. PatelPresident & Co-CEO, Director6,381,734——6,381,734—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 11, 2026 MForm 4 →Sep 14, 4:10 pm EDTJ Kevin BuchiDirector20,445——0—